<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02382601</url>
  </required_header>
  <id_info>
    <org_study_id>14-1360</org_study_id>
    <nct_id>NCT02382601</nct_id>
  </id_info>
  <brief_title>Longitudinal Study of Intra-Uterine Growth Restriction</brief_title>
  <official_title>Longitudinal Study of Intra-Uterine Growth Restriction (IUGR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Perelman Family Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigation will employ a longitudinal approach in which every fetus diagnosed to be
      SGA (Small for Gestational Age ) will be studied at frequent intervals with sophisticated
      imaging techniques to assess subtle physiologic changes in the brain, heart, and placenta
      over time. These findings will be correlated with neurological and cardiovascular function in
      the newborn and early childhood. This research initiative should yield diagnostic and
      therapeutic templates that will improve the quality of life of IUGR babies in addition to
      providing important information that will better inform current diagnostic practices.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overarching objective is to serially assess changes in the fetal circulation, heart, and
      brain with sophisticated ultrasound, MRI (Magnetic Resonance Imaging), and body composition
      techniques that will provide clues as to how growth restricted babies will tolerate life
      outside the uterus. Employing a longitudinal study will allow the investigators to correlate
      perinatal and postnatal outcomes more comprehensively than previous studies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterize the sequence of neurological and cardiovascular events defining early and late IUGR pathogenesis, respectively</measure>
    <time_frame>Every two weeks from the time of IUGR diagnosis or first visit</time_frame>
    <description>Using ultrasound and MRI to identify changes in the fetal vasculature, and fetal brain as early and late IUGR progress.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlate in utero adaptations in early and late IUGR, to infant and early childhood neurodevelopment</measure>
    <time_frame>Baseline (Day 0), 6 months, 1 year, and 2 years</time_frame>
    <description>Assess neurodevelopment with a series of tests (PSOM, Bayleys III, Mullen's Scale of Early Learning) and correlate neurological in utero findings to neurodevelopment outcomes at 40-44 weeks gestational age (baseline).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlate in utero adaptations in early and late IUGR, to infant and early childhood cardiovascular outcomes</measure>
    <time_frame>Baseline (Day 0), 6 months, 1 year, and 2 years</time_frame>
    <description>Assess cardiovascular health via echocardiograms at 40-44 weeks gestational age (baseline).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlate in utero adaptations in early and late IUGR, to infant and early childhood metabolic outcomes</measure>
    <time_frame>Baseline (Day 0), 6 months, 1 year, and 2 years</time_frame>
    <description>Correlate IUGR severity to metabolic outcomes as assessed by body composition (pea pod and bod pod with a pediatric attachment), and questionnaires on infant feeding: Infant Feeding Practices II, and Infant Feeding Questionnaire at 40-44 weeks gestational age (baseline).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare early IUGR, late IUGR and SGA infant and early childhood outcomes</measure>
    <time_frame>Baseline (Day 0), 6 months, 1 year, and 2 years</time_frame>
    <description>Using the tests describe above compare the outcomes of each group at 40-44 weeks gestational age (baseline).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>IUGR</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Small for Gestational Age Pregancies (controls)</arm_group_label>
    <description>Small for gestational age (SGA) pregnancies that do not develop IUGR will be considered controls. Each subject will have an ultrasound, MRI, maternal blood and cord blood collection, placental analysis, neurological function assessments (infant), and body fat measurements (infant).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IUGR Pregnancies (cases)</arm_group_label>
    <description>Small for gestational age (SGA) pregnancies that do develop IUGR will be considered cases. Each subject will have an ultrasound, MRI, maternal blood and cord blood collection, placental analysis, neurological function assessments (infant), and body fat measurements (infant).</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>With 3-D and 4-D high-resolution color Doppler methods it is possible to map out the placental circulation, fetal circulation, fetal brain, and fetal cardiac function. Investigators will collect these data points prenatally.</description>
    <arm_group_label>Small for Gestational Age Pregancies (controls)</arm_group_label>
    <arm_group_label>IUGR Pregnancies (cases)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>Similar to the Ultrasound data, investigators will collect MRI images of the fetal brain and the placenta. MRI will allow investigators to collect more detailed images of both the fetal brain and placenta, and investigators will be utilizing this technique both prenatally and postnatally.</description>
    <arm_group_label>Small for Gestational Age Pregancies (controls)</arm_group_label>
    <arm_group_label>IUGR Pregnancies (cases)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood collection</intervention_name>
    <description>The maternal and cord blood will be collected for the processing of plasma and serum. There may be early biomarkers of IUGR in the maternal circulation that investigators can use to better determine the appropriate strategy for clinical management of care. Collection and subsequent analysis of molecular markers in the umbilical cord blood will be used to further confirm physiological dysfunction as detected by ultrasound and MRI techniques.</description>
    <arm_group_label>Small for Gestational Age Pregancies (controls)</arm_group_label>
    <arm_group_label>IUGR Pregnancies (cases)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neurological Function Assessment</intervention_name>
    <description>Neurological development tests called a Bayley exam and Pediatric Stroke Outcome Measure (PSOM) will be performed.</description>
    <arm_group_label>Small for Gestational Age Pregancies (controls)</arm_group_label>
    <arm_group_label>IUGR Pregnancies (cases)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placental Analysis</intervention_name>
    <description>Placentas will undergo pathological evaluation for placental function.</description>
    <arm_group_label>Small for Gestational Age Pregancies (controls)</arm_group_label>
    <arm_group_label>IUGR Pregnancies (cases)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Measurement of body fat</intervention_name>
    <description>The baby's body fat will be measured in a special incubator called a PEAPOD or BODPOD when an infant.</description>
    <arm_group_label>Small for Gestational Age Pregancies (controls)</arm_group_label>
    <arm_group_label>IUGR Pregnancies (cases)</arm_group_label>
    <other_name>Peapod</other_name>
    <other_name>Bodpod</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Maternal peripheral blood and umbilical cord blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        University of Colorado School of Medicine is a referral center for women carrying fetuses
        with IUGR. Care providers routinely evaluate more than 300 patients per year at our
        outreach sites alone whose fetuses have estimated fetal weights below the 10th percentile.
        Of these, the investigators will initially enroll 200 patients per year between 24 and 36
        weeks over a two-year period.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with diagnosed SGA by an ultrasound estimated fetal weight (EFW) of less than
             the 10th percentile or a fetal abdominal circumference of less than the 5th percentile
             will be included in the study at the time of their first examination.

        Exclusion Criteria:

          -  Patients &lt; 18 years of age, and chromosomal anomalies as identified by regular
             aneuploidy screening.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Hobbins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane Gumina, MS</last_name>
    <email>diane.gumina@ucdenver.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chanel Mansfield, BBA</last_name>
    <phone>303-724-6501</phone>
    <email>chanel.mansfield@ucdenver.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado Denver Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Gumina, MS</last_name>
      <email>diane.gumina@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>John Hobbins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henry Galan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mike Zaretsky, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shane Reeves, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bettina Cuneo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisa Howley, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Mirsky, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariana Meyers, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Armstrong-Wells, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Brown, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miriam Post, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sean Deoni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Barker ED, McAuliffe FM, Alderdice F, Unterscheider J, Daly S, Geary MP, Kennelly MM, OʼDonoghue K, Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC, Malone FD. The role of growth trajectories in classifying fetal growth restriction. Obstet Gynecol. 2013 Aug;122(2 Pt 1):248-54. doi: 10.1097/AOG.0b013e31829ca9a7.</citation>
    <PMID>23969791</PMID>
  </reference>
  <reference>
    <citation>Mongelli M, Gardosi J. Reduction of false-positive diagnosis of fetal growth restriction by application of customized fetal growth standards. Obstet Gynecol. 1996 Nov;88(5):844-8.</citation>
    <PMID>8885925</PMID>
  </reference>
  <reference>
    <citation>Cruz-Martinez R, Figueras F, Hernandez-Andrade E, Puerto B, Gratacós E. Longitudinal brain perfusion changes in near-term small-for-gestational-age fetuses as measured by spectral Doppler indices or by fractional moving blood volume. Am J Obstet Gynecol. 2010 Jul;203(1):42.e1-6. doi: 10.1016/j.ajog.2010.02.049. Epub 2010 May 1.</citation>
    <PMID>20435282</PMID>
  </reference>
  <reference>
    <citation>Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackelöer BJ, Kok HJ, Senat MV, Visser GH. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol. 2001 Dec;18(6):564-70.</citation>
    <PMID>11844190</PMID>
  </reference>
  <reference>
    <citation>Ferrazzi E, Bozzo M, Rigano S, Bellotti M, Morabito A, Pardi G, Battaglia FC, Galan HL. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol. 2002 Feb;19(2):140-6.</citation>
    <PMID>11876805</PMID>
  </reference>
  <reference>
    <citation>Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, Baschat AA. Duration of persistent abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol. 2011 Sep;38(3):295-302. doi: 10.1002/uog.9011.</citation>
    <PMID>21465604</PMID>
  </reference>
  <reference>
    <citation>Acharya G. Measurement of atrioventricular annular plane displacement has been revived: will it prove to be useful in assessing fetal cardiac function? Ultrasound Obstet Gynecol. 2013 Aug;42(2):125-9. doi: 10.1002/uog.12542.</citation>
    <PMID>23775904</PMID>
  </reference>
  <reference>
    <citation>Kiserud T. Re: umbilical vein flow and perinatal outcome in term small-for-gestational-age fetuses. M. Parra-Saavedra, F. Crovetto, S. Triunfo, S. Savchev, G. Parra, M. Sanz, E. Gratacos and F. Figueras. Ultrasound Obstet Gynecol 2013; 42: 189-195. Ultrasound Obstet Gynecol. 2013 Aug;42(2):130. doi: 10.1002/uog.12553.</citation>
    <PMID>23893598</PMID>
  </reference>
  <reference>
    <citation>Odibo AO, Zhong Y, Longtine M, Tuuli M, Odibo L, Cahill AG, Macones GA, Nelson DM. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Placenta. 2011 Apr;32(4):333-8. doi: 10.1016/j.placenta.2011.01.016. Epub 2011 Feb 13.</citation>
    <PMID>21324404</PMID>
  </reference>
  <reference>
    <citation>Hafner E, Metzenbauer M, Stümpflen I, Waldhör T. Measurement of placental bed vascularization in the first trimester, using 3D-power-Doppler, for the detection of pregnancies at-risk for fetal and maternal complications. Placenta. 2013 Oct;34(10):892-8. doi: 10.1016/j.placenta.2013.06.303. Epub 2013 Jul 24.</citation>
    <PMID>23890468</PMID>
  </reference>
  <reference>
    <citation>Egaña-Ugrinovic G, Sanz-Cortes M, Figueras F, Bargalló N, Gratacós E. Differences in cortical development assessed by fetal MRI in late-onset intrauterine growth restriction. Am J Obstet Gynecol. 2013 Aug;209(2):126.e1-8. doi: 10.1016/j.ajog.2013.04.008. Epub 2013 Apr 9.</citation>
    <PMID>23583839</PMID>
  </reference>
  <reference>
    <citation>Figueras F, Cruz-Martinez R, Sanz-Cortes M, Arranz A, Illa M, Botet F, Costas-Moragas C, Gratacos E. Neurobehavioral outcomes in preterm, growth-restricted infants with and without prenatal advanced signs of brain-sparing. Ultrasound Obstet Gynecol. 2011 Sep;38(3):288-94. doi: 10.1002/uog.9041. Epub 2011 Aug 10.</citation>
    <PMID>21557369</PMID>
  </reference>
  <reference>
    <citation>Eixarch E, Meler E, Iraola A, Illa M, Crispi F, Hernandez-Andrade E, Gratacos E, Figueras F. Neurodevelopmental outcome in 2-year-old infants who were small-for-gestational age term fetuses with cerebral blood flow redistribution. Ultrasound Obstet Gynecol. 2008 Dec;32(7):894-9. doi: 10.1002/uog.6249.</citation>
    <PMID>19035538</PMID>
  </reference>
  <reference>
    <citation>Fowlkes JB, Holland CK. Mechanical bioeffects from diagnostic ultrasound: AIUM consensus statements. American Institute of Ultrasound in Medicine. J Ultrasound Med. 2000 Feb;19(2):69-72. Review.</citation>
    <PMID>10680613</PMID>
  </reference>
  <reference>
    <citation>Torloni MR, Vedmedovska N, Merialdi M, Betrán AP, Allen T, González R, Platt LD; ISUOG-WHO Fetal Growth Study Group. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol. 2009 May;33(5):599-608. doi: 10.1002/uog.6328. Review.</citation>
    <PMID>19291813</PMID>
  </reference>
  <reference>
    <citation>Ang ES Jr, Gluncic V, Duque A, Schafer ME, Rakic P. Prenatal exposure to ultrasound waves impacts neuronal migration in mice. Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12903-10. Epub 2006 Aug 10.</citation>
    <PMID>16901978</PMID>
  </reference>
  <reference>
    <citation>Salvesen KA, Eik-Nes SH. Ultrasound during pregnancy and subsequent childhood non-right handedness: a meta-analysis. Ultrasound Obstet Gynecol. 1999 Apr;13(4):241-6.</citation>
    <PMID>10341401</PMID>
  </reference>
  <reference>
    <citation>Newnham JP, Doherty DA, Kendall GE, Zubrick SR, Landau LL, Stanley FJ. Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age: follow-up of a randomised controlled trial. Lancet. 2004 Dec 4-10;364(9450):2038-44.</citation>
    <PMID>15582061</PMID>
  </reference>
  <reference>
    <citation>Schwartz JL, Crooks LE. NMR imaging produces no observable mutations or cytotoxicity in mammalian cells. AJR Am J Roentgenol. 1982 Sep;139(3):583-5.</citation>
    <PMID>6981326</PMID>
  </reference>
  <reference>
    <citation>Thomas A, Morris PG. The effects of NMR exposure on living organisms. I. A microbial assay. Br J Radiol. 1981 Jul;54(643):615-21.</citation>
    <PMID>6455175</PMID>
  </reference>
  <reference>
    <citation>Baker PN, Johnson IR, Harvey PR, Gowland PA, Mansfield P. A three-year follow-up of children imaged in utero with echo-planar magnetic resonance. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):32-3.</citation>
    <PMID>8296840</PMID>
  </reference>
  <reference>
    <citation>Simon EM, Goldstein RB, Coakley FV, Filly RA, Broderick KC, Musci TJ, Barkovich AJ. Fast MR imaging of fetal CNS anomalies in utero. AJNR Am J Neuroradiol. 2000 Oct;21(9):1688-98.</citation>
    <PMID>11039352</PMID>
  </reference>
  <reference>
    <citation>Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging. 2000 Aug;12(2):205-13. Review.</citation>
    <PMID>10931582</PMID>
  </reference>
  <reference>
    <citation>Victoria T, Jaramillo D, Roberts TP, Zarnow D, Johnson AM, Delgado J, Rubesova E, Vossough A. Fetal magnetic resonance imaging: jumping from 1.5 to 3 tesla (preliminary experience). Pediatr Radiol. 2014 Apr;44(4):376-86; quiz 373-5. doi: 10.1007/s00247-013-2857-0. Epub 2014 Mar 27. Review.</citation>
    <PMID>24671739</PMID>
  </reference>
  <reference>
    <citation>Savchev S, Figueras F, Cruz-Martinez R, Illa M, Botet F, Gratacos E. Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age pregnancies with normal fetal and maternal Doppler indices. Ultrasound Obstet Gynecol. 2012 Mar;39(3):299-303. doi: 10.1002/uog.10150. Epub 2012 Feb 7.</citation>
    <PMID>22102177</PMID>
  </reference>
  <reference>
    <citation>Chawengsettakul S, Russameecharoen K, Wanitpongpan P. Fetal cardiac function measured by myocardial performance index of small-for-gestational age fetuses. J Obstet Gynaecol Res. 2015 Feb;41(2):222-8. doi: 10.1111/jog.12508. Epub 2014 Aug 27.</citation>
    <PMID>25158601</PMID>
  </reference>
  <reference>
    <citation>Mailath-Pokorny M, Worda K, Schmid M, Polterauer S, Bettelheim D. Isolated single umbilical artery: evaluating the risk of adverse pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:80-3. doi: 10.1016/j.ejogrb.2014.11.007. Epub 2014 Nov 20.</citation>
    <PMID>25463640</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2015</study_first_submitted>
  <study_first_submitted_qc>March 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2015</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>IUGR</keyword>
  <keyword>Small for gestational age</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

